tiprankstipranks
Advertisement
Advertisement

GDRX Stock Latest News

GoodRx Reshapes Board After Director Resignation and Reclassification
Company AnnouncementsGoodRx Reshapes Board After Director Resignation and Reclassification
6d ago
8K
GDRX
GoodRx Chief Accounting Officer Resigns for New Opportunity
PremiumCompany Announcements
GoodRx Chief Accounting Officer Resigns for New Opportunity
13d ago
8K
GDRX
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
PremiumThe Fly
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
13d ago
GDRX
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
PremiumMarket News
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
21d ago
CVS
NVO
GoodRx Awards Performance-Based Bonus to Chief Accounting Officer
PremiumCompany Announcements
GoodRx Awards Performance-Based Bonus to Chief Accounting Officer
1M ago
8K
GDRX
GoodRx to team with Eli Lilly to expand employer-sponsored access to Zepbound
PremiumThe FlyGoodRx to team with Eli Lilly to expand employer-sponsored access to Zepbound
1M ago
LLY
GDRX
GoodRx price target lowered to $3.50 from $7 at Wells Fargo
Premium
The Fly
GoodRx price target lowered to $3.50 from $7 at Wells Fargo
1M ago
GDRX
GoodRx price target lowered to $3.50 from $7 at Wells Fargo
Premium
The Fly
GoodRx price target lowered to $3.50 from $7 at Wells Fargo
1M ago
GDRX
GoodRx price target lowered to $3.50 from $4.50 at Citi
PremiumThe Fly
GoodRx price target lowered to $3.50 from $4.50 at Citi
1M ago
GDRX
GoodRx price target lowered to $2.50 from $4 at Goldman Sachs
PremiumThe Fly
GoodRx price target lowered to $2.50 from $4 at Goldman Sachs
1M ago
GDRX
GoodRx Earnings Call Marks Transitional Reset Year
PremiumCompany Announcements
GoodRx Earnings Call Marks Transitional Reset Year
1M ago
GDRX
GoodRx Announces Resignation of Board Member Dipanjan Deb
PremiumCompany Announcements
GoodRx Announces Resignation of Board Member Dipanjan Deb
1M ago
8K
GDRX
GoodRx price target lowered to $3 from $6 at Deutsche Bank
PremiumThe FlyGoodRx price target lowered to $3 from $6 at Deutsche Bank
1M ago
GDRX
GoodRx price target lowered to $3 from $6 at TD Cowen
Premium
The Fly
GoodRx price target lowered to $3 from $6 at TD Cowen
1M ago
GDRX
GoodRx price target lowered to $2 from $4 at UBS
Premium
The Fly
GoodRx price target lowered to $2 from $4 at UBS
1M ago
GDRX
GoodRx price target lowered to $2 from $4 at UBS
PremiumThe Fly
GoodRx price target lowered to $2 from $4 at UBS
1M ago
GDRX
Balancing Near-Term Headwinds and Long-Term Growth: Justifying a Buy/High-Risk Rating on Pharma Direct-Led Upside
PremiumRatings
Balancing Near-Term Headwinds and Long-Term Growth: Justifying a Buy/High-Risk Rating on Pharma Direct-Led Upside
1M ago
GDRX
GoodRx price target lowered to $3 from $4 at Mizuho
PremiumThe Fly
GoodRx price target lowered to $3 from $4 at Mizuho
1M ago
GDRX
GoodRx downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
GoodRx downgraded to Neutral from Overweight at JPMorgan
1M ago
GDRX
GoodRx downgraded to Neutral at JPMorgan on ‘murky’ outlook
PremiumThe FlyGoodRx downgraded to Neutral at JPMorgan on ‘murky’ outlook
1M ago
GDRX
GoodRx: Weakened Long‑Term Outlook and Structural Headwinds Support Sell Rating
Premium
Ratings
GoodRx: Weakened Long‑Term Outlook and Structural Headwinds Support Sell Rating
1M ago
GDRX
Closing Bell Movers: Nvidia pares post-earnings gains
Premium
The Fly
Closing Bell Movers: Nvidia pares post-earnings gains
1M ago
AI
ZM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >